Prospective evaluation of patient-reported anxiety and experiences with adaptive radiation therapy on an MR-linac.

Adaptive radiotherapy Anxiety MR-linac Patient experience

Journal

Technical innovations & patient support in radiation oncology
ISSN: 2405-6324
Titre abrégé: Tech Innov Patient Support Radiat Oncol
Pays: England
ID NLM: 101762366

Informations de publication

Date de publication:
Mar 2024
Historique:
received: 28 11 2023
revised: 13 02 2024
accepted: 26 02 2024
medline: 6 3 2024
pubmed: 6 3 2024
entrez: 6 3 2024
Statut: epublish

Résumé

An integrated magnetic resonance scanner and linear accelerator (MR-linac) was implemented with daily online adaptive radiation therapy (ART). This study evaluated patient-reported experiences with their overall hospital care as well as treatment in the MR-linac environment. Patients pre-screened for MR eligibility and claustrophobia were referred to simulation on a 1.5 T MR-linac. Patient-reported experience measures were captured using two validated surveys. The 15-item MR-anxiety questionnaire (MR-AQ) was administered immediately after the first treatment to rate MR-related anxiety and relaxation. The 40-item satisfaction with cancer care questionnaire rating doctors, radiation therapists, the services and care organization and their outpatient experience was administered immediately after the last treatment using five-point Likert responses. Results were analyzed using descriptive statistics. 205 patients were included in this analysis. Multiple sites were treated across the pelvis and abdomen with a median treatment time per fraction of 46 and 66 min respectively. Patients rated MR-related anxiety as "not at all" (87%), "somewhat" (11%), "moderately" (1%) and "very much so" (1%). Positive satisfaction responses ranged from 78 to 100% (median 93%) across all items. All radiation therapist-specific items were rated positively as 96-100%. The five lowest rated items (range 78-85%) were related to general provision of information, coordination, and communication. Overall hospital care was rated positively at 99%. In this large, single-institution prospective cohort, all patients had low MR-related anxiety and completed treatment as planned despite lengthy ART treatments with the MR-linac. Patients overall were highly satisfied with their cancer care involving ART using an MR-linac.

Identifiants

pubmed: 38445180
doi: 10.1016/j.tipsro.2024.100240
pii: S2405-6324(24)00007-6
pmc: PMC10912905
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100240

Informations de copyright

© 2024 The Author(s).

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Amanda Moreira (A)

Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Winnie Li (W)

Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Department of Radiation Oncology, University of Toronto, Toronto, Canada.

Alejandro Berlin (A)

Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Department of Radiation Oncology, University of Toronto, Toronto, Canada.

Cathy Carpino-Rocca (C)

Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Peter Chung (P)

Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Department of Radiation Oncology, University of Toronto, Toronto, Canada.

Leigh Conroy (L)

Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Department of Radiation Oncology, University of Toronto, Toronto, Canada.

Jennifer Dang (J)

Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Laura A Dawson (LA)

Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Department of Radiation Oncology, University of Toronto, Toronto, Canada.

Rachel M Glicksman (RM)

Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Department of Radiation Oncology, University of Toronto, Toronto, Canada.

Ali Hosni (A)

Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Department of Radiation Oncology, University of Toronto, Toronto, Canada.

Harald Keller (H)

Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Department of Radiation Oncology, University of Toronto, Toronto, Canada.

Vickie Kong (V)

Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Department of Radiation Oncology, University of Toronto, Toronto, Canada.

Patricia Lindsay (P)

Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Department of Radiation Oncology, University of Toronto, Toronto, Canada.

Andrea Shessel (A)

Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Teo Stanescu (T)

Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Department of Radiation Oncology, University of Toronto, Toronto, Canada.

Edward Taylor (E)

Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Department of Radiation Oncology, University of Toronto, Toronto, Canada.

Jeff Winter (J)

Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Department of Radiation Oncology, University of Toronto, Toronto, Canada.

Michael Yan (M)

Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Department of Radiation Oncology, University of Toronto, Toronto, Canada.

Daniel Letourneau (D)

Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Department of Radiation Oncology, University of Toronto, Toronto, Canada.

Michael Milosevic (M)

Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Department of Radiation Oncology, University of Toronto, Toronto, Canada.

Michael Velec (M)

Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Department of Radiation Oncology, University of Toronto, Toronto, Canada.

Classifications MeSH